CASTLE BIOSCIENCES INC
For the period ended May 28, 2026. Filed Apr 8, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 28, 2026 · Filed Apr 8, 2026
CSTL$32.52-4.9%Stored close · as of Nov 6, 2026
Contents
Castle Biosciences 2026 Proxy Statement55
| Castle Biosciences 2026 Proxy Statement | 55 |
|---|
| Compensation Discussion and Analysis | Table of Contents |
|---|
Changes from Prior Peer Group(1)
| Added for 2025 | Removed for 2025 |
|---|---|
| Cytek Biosciences, Inc. (CKTB) | Invitae Corporation (NVTAQ) |
| GeneDx Holdings Corp. (WGS) | Natera, Inc. (NTRA) |
| Maravai Lifesciences Holdings, Inc. (MVRVI) | |
(1)Primarily due to change in revenue, market value, and/or being acquired.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.